ConnectiveRx Advances Clinically Integrated Provider Engagement Network

Read the official Press Release here

WHIPPANY, N.J. — ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today highlighted the scale and precision of its clinically integrated provider engagement network, spanning the full prescribing landscape – from the nation's leading health system EHRs to the outpatient and specialty settings where care is continuously delivered.

ConnectiveRx's network reaches more than 1.2 million providers inside workflows and at the point of care. Those interactions generate physician-level data (PLD) tied to actual prescribing activity, giving manufacturer and agency partners a real-world view of how providers engage and prescribe.

In terms of reaching an ideal prescriber base for a medication brand, major EHR platforms are a starting point, not a complete strategy. For specialty and chronic therapies, the majority of prescribing decisions occur in the ambulatory setting. It is not a new insight for ConnectiveRx; it is the foundation the network was built on. Manufacturer and agency partners benefit from the reach, targeting precision, and clinical context needed to engage priority HCPs where prescribing intent is actually highest.

“Medication brand messaging tied to therapeutic context, patient characteristics, and the act of prescribing itself has proven to increase first-fill rates and adherence to continued therapy," said ConnectiveRx SVP of Messaging Operations Lisa Prowker. "In-workflow messaging campaigns eclipse the performance of other channels, so our network is designed to ensure medication brands can engage providers across the full prescribing landscape, with the campaign transparency and data sophistication today's pharmaceutical partners expect.”